iiinova — where your digital self keeps evolving

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 16/02/2026

Mark your calendars, this April ECi are delivering a week long cost-effectiveness modelling course for health technology. Find out how to join below. 👇🏼 cancer-data.ecrc.ed.ac.uk/2026/02/16/c...

cancer-data.ecrc.ed.ac.uk

Cost Effectiveness Modelling Course – Edinburgh Cancer Informatics

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 27/01/2026

Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across Europe. Our first published paper of 2026, read all about it below. www.sciencedirect.com/science/arti...

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 17/12/2025

We're starting 2026 with a bang. 💥 From 5th-8th January, we are delivering an oncology statistics course in collaboration with NES. Read more here: cancer-data.ecrc.ed.ac.uk/oncology-sta...

cancer-data.ecrc.ed.ac.uk

Oncology Statistics – Edinburgh Cancer Informatics

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 18/11/2025

Led by Dr Iain Phillips and supported by several members of our team, we have successfully published our paper Multi-disciplinary Prehabilitation in Lung Cancer Patients. 🎉 Take a look below 👇🏼

cancer-data.ecrc.ed.ac.uk

Multi-disciplinary Prehabilitation in Lung Cancer Patients – Edinburgh Cancer Informatics

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 04/06/2025

A new collaboration with Movember is underway within the team, with Kevin Gallagher leading a project centred around prostate cancer equity. 🥸

cancer-data.ecrc.ed.ac.uk

Movember Prostate Cancer Equity Metric Project – Edinburgh Cancer Informatics

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 29/04/2025

ECi were recently invited to showcase our projects at the 2025 CRUK Parliament Reception. Read more about it on our website 👇 cancer-data.ecrc.ed.ac.uk/2025/04/29/e...

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 07/03/2025

We're hiring! A vacancy has opened up in the team for the position of Post-Doctoral Research Fellow. 🔬 🧑🏼‍💻 If this sounds like something you'd be interested in, details can be found on our website below. 👇 cancer-data.ecrc.ed.ac.uk/2025/03/07/r...

001

Reposted by Edinburgh Cancer Informatics

Peter Hall @peterhall001.bsky.social · 02/12/2024

The Sudlow Review on the challenges and opportunities for using UK linked healthcare data for research www.hdruk.ac.uk/helping-with...

hdruk.ac.uk

011

Reposted by Edinburgh Cancer Informatics

Peter Hall @peterhall001.bsky.social · 18/11/2024

Looking for collaborators to work on federated Real World Evidence studies related to cancer. We are building our infrastructure and need high value demonstaror projects. #OHDSI #EHDEN #OMOP #RWE please get in touch

152

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 18/11/2024

DataLoch, in collaboration with ECi are proud to announce our membership of the UK RWE Network. Operated by HDR UK, we aim to prove the potential of Observational Medical Outcomes Partnership (OMOP) and the Common Data Model (CDM). Find out more below👇🏼 t.co/rj89DIgT4b

030

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 18/11/2024

Read more about the OMOP Common Data Model used in our studies. 💻 t.co/ukStMLuvgc

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 18/11/2024

Your coffee break reading, sorted. ☕️ Read below to discover the impact of SABR on Stage 1 Non-Small-Cell Cancer Outcomes. 👇 t.co/seMWlyos26

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 18/11/2024

𝘓𝘶𝘯𝘨 𝘤𝘢𝘯𝘤𝘦𝘳 𝘪𝘴 𝘵𝘩𝘦 𝘮𝘰𝘴𝘵 𝘤𝘰𝘮𝘮𝘰𝘯 𝘤𝘢𝘶𝘴𝘦 𝘰𝘧 𝘤𝘢𝘯𝘤𝘦𝘳 𝘥𝘦𝘢𝘵𝘩 𝘪𝘯 𝘵𝘩𝘦 𝘜𝘒. We teamed up with @cruk-si.bsky.social and NHS Lothian to assess whether early prehabilitation could be feasible in these patients. 👇 t.co/hgeiPjw7bZ

000

Edinburgh Cancer Informatics @cancerdataedin.bsky.social · 18/11/2024

Take a deep dive into Piyumanga's incredible research project, where she explores the topic of polypharmacy-survival in poor prognosis cancer patients. 🤿 👇 t.co/Azd0gPf885

000